Unwin to continue running Global Technology fund
Due to larger wallet size
Number of stocks reset to $123.47
How are fund houses embracing socal media?
BB Biotech's Head of Investment, Daniel Koller, explains why the sector's fundamentals are all lined up to the upside.
Head of Investment at BB Biotech, Daniel Koller, discusses sector growth and the attractive valuations of fast growing companies.
Jonathan Hammond, managing consultant and institutional technology practice lead at Knadel, assesses how consolidation in the software market raises questions for the asset management industry.
'Big five' tech stocks hit recently